These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12856652)

  • 1. Protection of research subjects.
    Tremaine WJ
    N Engl J Med; 2003 Jul; 349(2):188-92; author reply 188-92. PubMed ID: 12856652
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of research subjects.
    Pesando JM
    N Engl J Med; 2003 Jul; 349(2):188-92; author reply 188-92. PubMed ID: 12856655
    [No Abstract]   [Full Text] [Related]  

  • 3. Recruiting human subjects without IRB review/approval.
    Maloney DM
    Hum Res Rep; 2002 Aug; 17(8):3. PubMed ID: 12731493
    [No Abstract]   [Full Text] [Related]  

  • 4. Trial design and patient safety--the debate continues.
    Steinbrook R
    N Engl J Med; 2003 Aug; 349(7):629-30. PubMed ID: 12917298
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection of research subjects.
    Noble JH; Sharav VH
    N Engl J Med; 2003 Jul; 349(2):188-92; author reply 188-92. PubMed ID: 12856654
    [No Abstract]   [Full Text] [Related]  

  • 6. Continued concern: human subject protection, the institutional review board, and continuing review.
    Hoffman S
    Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
    [No Abstract]   [Full Text] [Related]  

  • 7. Research involving children: regulations, review boards and reform.
    Gandhi R
    J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
    [No Abstract]   [Full Text] [Related]  

  • 8. Federal drug agency gets flack about human subjects protections in clinical trials.
    Beckman M
    J Natl Cancer Inst; 2008 Jan; 100(2):90-1. PubMed ID: 18182612
    [No Abstract]   [Full Text] [Related]  

  • 9. Financial conflicts of interest and protection of human research subjects.
    Maloney DM
    Hum Res Rep; 2004 Jun; 19(6):1-2. PubMed ID: 15462034
    [No Abstract]   [Full Text] [Related]  

  • 10. The basics of human subjects protection.
    Yoder LH
    Medsurg Nurs; 2006 Apr; 15(2):95-8; quiz 99. PubMed ID: 16700248
    [No Abstract]   [Full Text] [Related]  

  • 11. An instrument to differentiate between clinical research and quality improvement.
    Ogrinc G; Nelson WA; Adams SM; O'Hara AE
    IRB; 2013; 35(5):1-8. PubMed ID: 24350502
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethics. Human health research ethics.
    Silbergeld E; Lerman S; Hushka L
    Science; 2004 Aug; 305(5686):949. PubMed ID: 15310879
    [No Abstract]   [Full Text] [Related]  

  • 13. Reporting problems in human research and resultant investigations by IRBs.
    Maloney DM
    Hum Res Rep; 2002 Aug; 17(8):6-7. PubMed ID: 12731495
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical research. Shutdown at Hopkins sparks a debate.
    Marshall E
    Science; 2001 Jul; 293(5530):587-9. PubMed ID: 11474076
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlling research trials.
    Drazen JM
    N Engl J Med; 2003 Apr; 348(14):1377-80. PubMed ID: 12672866
    [No Abstract]   [Full Text] [Related]  

  • 16. Make clinical research top priority.
    Prophet S
    J AHIMA; 2002 Jan; 73(1):19-20. PubMed ID: 12469657
    [No Abstract]   [Full Text] [Related]  

  • 17. The Office of Human Research Protections.
    Chamberlain B
    Clin Nurse Spec; 2008; 22(6):268. PubMed ID: 18955842
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of escalating regulatory requirements on the conduct of clinical research.
    Gordon BG; Kessinger A; Mann SL; Prentice ED
    Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ethics committees in USA--background and development. Responsible conductors of clinical trials required for risk minimization].
    Lund LH
    Lakartidningen; 2008 Jan 9-15; 105(1-2):42-4. PubMed ID: 18293746
    [No Abstract]   [Full Text] [Related]  

  • 20. Protecting vulnerable research subjects: practical realities of institutional review board review and approval.
    Wichman A
    J Health Care Law Policy; 1998; 1(1):88-104. PubMed ID: 15573431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.